CN105263893A - 环己烯酮组成物及其制备方法 - Google Patents

环己烯酮组成物及其制备方法 Download PDF

Info

Publication number
CN105263893A
CN105263893A CN201480022436.9A CN201480022436A CN105263893A CN 105263893 A CN105263893 A CN 105263893A CN 201480022436 A CN201480022436 A CN 201480022436A CN 105263893 A CN105263893 A CN 105263893A
Authority
CN
China
Prior art keywords
alkyl
compound
independently
formula
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480022436.9A
Other languages
English (en)
Chinese (zh)
Inventor
刘胜勇
温武哲
陈志铭
郑秀宜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Golden Biotechnology Corp
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of CN105263893A publication Critical patent/CN105263893A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201480022436.9A 2013-02-20 2014-02-20 环己烯酮组成物及其制备方法 Pending CN105263893A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767212P 2013-02-20 2013-02-20
US61/767,212 2013-02-20
PCT/US2014/017284 WO2014130618A1 (en) 2013-02-20 2014-02-20 Cyclohexenone compositions and process for making thereof

Publications (1)

Publication Number Publication Date
CN105263893A true CN105263893A (zh) 2016-01-20

Family

ID=51391788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480022436.9A Pending CN105263893A (zh) 2013-02-20 2014-02-20 环己烯酮组成物及其制备方法

Country Status (9)

Country Link
US (2) US9365481B2 (https=)
EP (1) EP2958883B1 (https=)
JP (2) JP6706018B2 (https=)
CN (1) CN105263893A (https=)
CA (1) CA2901581C (https=)
ES (1) ES2713181T3 (https=)
HK (1) HK1220174A1 (https=)
TW (1) TWI612026B (https=)
WO (1) WO2014130618A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108503523A (zh) * 2017-02-24 2018-09-07 郭盈妤 分离自牛樟芝的化合物及其用途
CN109069448A (zh) * 2016-02-17 2018-12-21 国鼎生物科技股份有限公司 用于治疗肝癌的组合物和方法
CN111018686A (zh) * 2019-11-19 2020-04-17 南通大学 6-苄亚基-2-芳基乙炔基环己烯酮衍生物及其制备方法和医药用途

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI612026B (zh) * 2013-02-20 2018-01-21 國鼎生物科技股份有限公司 環己烯酮組成物及其製造方法
WO2016037566A1 (en) * 2014-09-09 2016-03-17 Ching-Feng Weng Use of antroqiononol for treating obesity, and process for preparation of antroquinonol
US20160237012A1 (en) * 2015-02-17 2016-08-18 Golden Biotechnology Corporation Anticancer agents and process of making thereof
US11406605B2 (en) 2017-12-20 2022-08-09 Golden Biotechnology Corporation Therapeutic compositions for treating pancreatic cancer
AU2018247249B2 (en) 2017-12-20 2023-10-19 Golden Biotechnology Corporation Therapeutic compositions for treating pancreatic cancer
BR112022022146A2 (pt) 2020-05-08 2023-03-14 Golden Biotechnology Corp Métodos e composições para tratar uma doença induzida por vírus de rna
WO2025165622A1 (en) * 2024-01-31 2025-08-07 Golden Biotechnology Corporation Therapeutic compositions for treating liver cancer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210869A1 (en) * 2009-02-13 2010-08-19 Kaohsiung Medical University Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof
US20110060058A1 (en) * 2009-09-09 2011-03-10 Golden Biotechnology Corporation Inhibition of the Survival of Ovarian Cancer by Cyclohexenone Compounds from Antrodia Camphorata
US20110059123A1 (en) * 2009-09-09 2011-03-10 Golden Biotechnology Corporation Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata
US20120309732A1 (en) * 2011-05-31 2012-12-06 Mackay Memorial Hospital METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL
US20130005825A1 (en) * 2009-09-09 2013-01-03 Golden Biotechnology Corporation Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200829234A (en) * 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
AU2012267893A1 (en) * 2011-06-10 2013-12-19 Golden Biotechnology Corporation Methods and compositions for treating brain cancer
TWI612026B (zh) * 2013-02-20 2018-01-21 國鼎生物科技股份有限公司 環己烯酮組成物及其製造方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210869A1 (en) * 2009-02-13 2010-08-19 Kaohsiung Medical University Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof
US20110060058A1 (en) * 2009-09-09 2011-03-10 Golden Biotechnology Corporation Inhibition of the Survival of Ovarian Cancer by Cyclohexenone Compounds from Antrodia Camphorata
US20110059123A1 (en) * 2009-09-09 2011-03-10 Golden Biotechnology Corporation Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata
US20130005825A1 (en) * 2009-09-09 2013-01-03 Golden Biotechnology Corporation Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata
US20120309732A1 (en) * 2011-05-31 2012-12-06 Mackay Memorial Hospital METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069448A (zh) * 2016-02-17 2018-12-21 国鼎生物科技股份有限公司 用于治疗肝癌的组合物和方法
CN108503523A (zh) * 2017-02-24 2018-09-07 郭盈妤 分离自牛樟芝的化合物及其用途
CN111018686A (zh) * 2019-11-19 2020-04-17 南通大学 6-苄亚基-2-芳基乙炔基环己烯酮衍生物及其制备方法和医药用途
CN111018686B (zh) * 2019-11-19 2020-09-22 南通大学 6-苄亚基-2-芳基乙炔基环己烯酮衍生物及其制备方法和医药用途

Also Published As

Publication number Publication date
JP2019142854A (ja) 2019-08-29
JP6706018B2 (ja) 2020-06-03
HK1220174A1 (zh) 2017-04-28
EP2958883A4 (en) 2016-08-17
ES2713181T3 (es) 2019-05-20
WO2014130618A1 (en) 2014-08-28
CA2901581C (en) 2020-07-14
TWI612026B (zh) 2018-01-21
US20150018567A1 (en) 2015-01-15
TW201500330A (zh) 2015-01-01
US9365481B2 (en) 2016-06-14
EP2958883B1 (en) 2019-01-30
CA2901581A1 (en) 2014-08-28
EP2958883A1 (en) 2015-12-30
US20160251308A1 (en) 2016-09-01
JP2016513122A (ja) 2016-05-12

Similar Documents

Publication Publication Date Title
CN105263893A (zh) 环己烯酮组成物及其制备方法
JP6757565B2 (ja) ジヒドロピリミジン−２−オン化合物およびその医薬用途
RS62515B1 (sr) Prekursor leka – derivat aminokiselina
Garcia Ruano et al. Highly diastereoselective hydrocyanation of. beta.-keto sulfoxides: synthesis of enantiomerically pure cyanohydrin derivatives
Chernykh et al. Synthesis of fluorinated building blocks based on spiro [3.3] heptane scaffold
SK2262000A3 (en) Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
Dudziński et al. Synthesis and [3, 3]-sigmatropic rearrangements of 5-(pentafluorosulfanyl)-pent-3-en-2-ol, its homologues, and trifluoromethyl analogues
CN1365278A (zh) 作为安全有效抗疟剂的水溶性三噁烷
EP4269388A1 (en) Dipyrromethene-1-one compound and preparation method therefor
Mykhaylychenko et al. Oxidation and chlorination reactions of perfluoroketene-N, S-acetals
CN115536511B (zh) 1,4-二醛酮化合物、其合成方法及应用
Sato et al. Access of cis-4-monofluoromethyl-1, 3-oxazolidines via a formal [3+ 2] cycloaddition triggered by BF3• OEt2
Bruno et al. Facile entry to ethyl tetrahydro-1H-pyrrolizin-7a (5H)-ylacetate: a versatile pharmaceutical intermediate
JP2005126340A (ja) 置換ピリドン類の製造法、その原料化合物及びその製造方法
EA010020B1 (ru) Соединение карбоновой кислоты и лекарственное средство, его включающее
Youn Methods and Strategies for Synthesis:(a) New methods for highly functionalized quinolines,(b) Synthetic studies toward Adriatoxin B, and (c) Total synthesis and structure assignment of Nosperin
JP3097678B2 (ja) アファノルフィン中間体
JP4523761B2 (ja) 抗腫瘍活性を有する新規化合物、およびその製造方法
CN116606232A (zh) 一种新型单氟烷基类化合物、制备方法及其应用
KR20050012432A (ko) 아토르바스타틴 합성 중간체의 제조방법
GR20230200129U (el) Ενωσεις για την ανιχνευση της λιγανδρολης
JP2022529064A (ja) チオ―ルまたはジスルフィド含有メイタンシノイドエステルおよびその中間体の調製のためのジアステロ選択的方法
TWI417289B (zh) 製備具光學活性安卓幸之製程
Weaver Frisky Dienes & Hot Electrophiles: Development of synthetic methods to access key structural features of tetrapetalone A
Yeh Synthetic studies of biologically active alkaloids: asymmetric synthetic approaches to epibatidine and halichlorine.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1220174

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160120

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1220174

Country of ref document: HK